Covered recipient · General Payments record
LISA CHRISTOPHER
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2020–2025
$92,262.26
- Reported across 84 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $16,339.00 | 7 |
| Travel and Lodging | $743.76 | 3 |
| Food and Beverage | $283.32 | 4 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $8,456.00 | 4 |
| WERFEN USA LLC | $5,372.34 | 5 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,740.00 | 1 |
| Alexion Pharmaceuticals, Inc. | $1,225.00 | 1 |
| Janssen Research & Development, LLC | $460.00 | 1 |
| ARGENX US, INC. | $97.74 | 1 |
| Octapharma USA, Inc. | $15.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Alexion Pharmaceuticals, Inc. | $1,225.00 | 06/08/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1202950482 | CMS |
| ARGENX US, INC. | $97.74 | 10/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1240449498 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,740.00 | 07/11/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1222797373 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.00 | 01/06/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1184592301 | CMS |
| E.R. Squibb & Sons, L.L.C. | $2,800.00 | 07/15/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1184592299 | CMS |
| E.R. Squibb & Sons, L.L.C. | $42.00 | 12/23/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1184592147 | CMS |
| E.R. Squibb & Sons, L.L.C. | $5,600.00 | 12/23/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1184592239 | CMS |
| Janssen Research & Development, LLC | $460.00 | 06/19/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1173803061 | CMS |
| Octapharma USA, Inc. | $15.00 | 10/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1245076203 | CMS |
| WERFEN USA LLC | $93.41 | 05/31/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233965285 | CMS |
| WERFEN USA LLC | $4,500.00 | 06/27/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1233965277 | CMS |
| WERFEN USA LLC | $574.04 | 06/27/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1233965279 | CMS |
| WERFEN USA LLC | $77.17 | 06/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233965281 | CMS |
| WERFEN USA LLC | $127.72 | 06/27/2025 | Travel and Lodging | Undisputed | 06/30/2026 | 1233965283 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2020, 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.